Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Pfizer
(NY:
PFE
)
25.62
-0.42 (-1.61%)
Official Closing Price
Updated: 7:00 PM EDT, Jun 8, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
42,132,608
Open
25.97
Bid (Size)
25.65 (800)
Ask (Size)
25.67 (1,600)
Prev. Close
26.04
Today's Range
25.60 - 26.21
52wk Range
23.11 - 28.75
Shares Outstanding
5,606,688,356
Dividend Yield
6.71%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Pfizer's Obesity Drug Shows 16% Weight Loss In Phase 2b Study
↗
June 08, 2026
Pfizer reports Phase 2b obesity drug data showing 15.9% weight loss as FDA expands HYMPAVZI use for hemophilia patients.
Via
Benzinga
Curious about the most active S&P500 stocks in today's session?
↗
June 08, 2026
Via
Chartmill
Performance
YTD
+1.7%
+1.7%
1 Month
-0.7%
-0.7%
3 Month
-4.4%
-4.4%
6 Month
-0.6%
-0.6%
1 Year
+6.9%
+6.9%
More News
Read More
Hemostat Powder Market Size, Analysis Report By 2035
↗
June 08, 2026
Via
Talk Markets
Topics
Economy
U.S. FDA Approves Pfizer’s HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need
June 08, 2026
From
Pfizer Inc.
Via
Business Wire
Is AbbVie the Most Underrated Dividend Growth Stock in the S&P 500?
↗
June 08, 2026
Via
The Motley Fool
Topics
Intellectual Property
Stocks
3 Dividend Stocks to Buy Hand Over Fist in June
↗
June 07, 2026
Via
The Motley Fool
Topics
Intellectual Property
Can Pfizer's Dividend Survive the Patent Cliff? This $10.5 Billion Cancer Bet Could Hold the Answer.
↗
June 06, 2026
Via
The Motley Fool
Topics
Intellectual Property
Pfizer's 6.7% Yield Looks Scary -- but the Dividend Story Is Stronger Than It Seems
↗
June 06, 2026
Via
The Motley Fool
Topics
Intellectual Property
Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer’s GLP-1 RA Berobenatide
June 06, 2026
From
Pfizer Inc.
Via
Business Wire
Arvinas Sharpens Pipeline Focus After First PROTAC Approval, Eyes Key Trial Data
↗
June 05, 2026
Via
MarketBeat
2 Cash-Producing Stocks Worth Your Attention and 1 Facing Headwinds
June 05, 2026
Via
StockStory
Aclaris Therapeutics Maps Busy Pipeline Calendar, Plans Phase 2 Asthma Trial for ATI-052
↗
June 04, 2026
Via
MarketBeat
Better High-Yield Dividend Stock to Buy: Bristol Myers Squibb or Pfizer?
↗
June 04, 2026
Via
The Motley Fool
Avascular Necrosis Market Size, Industry Share By 2035
↗
June 04, 2026
Via
Talk Markets
Topics
Economy
3 Absurdly Cheap Dividend Stocks to Buy With $1,000 Right Now
↗
June 03, 2026
Via
The Motley Fool
Bristol Myers vs. Pfizer: Which High‑Yield Dividend Stock Wins Now?
↗
June 03, 2026
Via
The Motley Fool
Topics
Intellectual Property
Meet the Biotech Stock That's Trouncing Lilly, Merck, and Pfizer in 2026
↗
June 03, 2026
Via
The Motley Fool
3 Large-Cap Stocks with Solid Fundamentals
June 03, 2026
Via
StockStory
How to Recession-Proof Your Retirement Before the Second Half of 2026
↗
June 02, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
ETFs
Economy
3 Dividend Stocks to Buy and Hold Forever
↗
June 02, 2026
Via
The Motley Fool
Why Bristol Myers Squibb Stock Isn't Nearly As Cheap As It Looks
↗
June 01, 2026
Via
The Motley Fool
Topics
Intellectual Property
AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?
↗
June 01, 2026
Via
The Motley Fool
Topics
Intellectual Property
CRISPR Therapeutics' Secret Weapon That Many Investors Are Overlooking
↗
June 01, 2026
Via
The Motley Fool
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
June 01, 2026
From
Pfizer Inc.
Via
Business Wire
Is Pfizer the Perfect Stock to Own with Kevin Warsh Heading the Fed?
↗
June 01, 2026
Via
The Motley Fool
Topics
Economy
Frequently Asked Questions
Is Pfizer publicly traded?
Yes, Pfizer is publicly traded.
What exchange does Pfizer trade on?
Pfizer trades on the New York Stock Exchange
What is the ticker symbol for Pfizer?
The ticker symbol for Pfizer is PFE on the New York Stock Exchange
What is the current price of Pfizer?
The current price of Pfizer is 25.62
When was Pfizer last traded?
The last trade of Pfizer was at 06/08/26 07:00 PM ET
What is the market capitalization of Pfizer?
The market capitalization of Pfizer is 143.64B
How many shares of Pfizer are outstanding?
Pfizer has 144B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.